CX3CR1 Deficiency Attenuates Endometriotic Lesion Growth through Reduced M2 Macrophage Polarization in a Murine Model
Endometriosis is a chronic inflammatory disease characterized by immune dysregulation and an altered peritoneal microenvironment. Macrophages are abundant within endometriotic lesions and are thought to contribute to lesion persistence, angiogenesis, and immune evasion. The receptor CX3CR1 has been implicated in macrophage recruitment and polarization and has been reported to be upregulated in endometriosis. However, its role in endometriosis progression in vivo remains unknown. Experimental endometriosis was induced in wild-type (WT, n = 8) and CX3CR1 knockout (KO, n = 7) C57BL/6 mice. Lesions were allowed to develop for seven weeks before evaluation. Lesion volume was quantified macroscopically, and lesion number was recorded. Immunohistochemistry was performed for CX3CR1, the M2 macrophage marker CD163, and M1 macrophage marker iNOS. CD163 mRNA expression was assessed by quantitative real-time PCR. CX3CR1 deficiency resulted in a significant reduction in endometriotic lesion volume compared with WT controls. Immunohistochemical analysis confirmed CX3CR1 expression in WT lesions and absent staining in KO lesions. The number of CD163-positive cells per mm2 were significantly reduced in CX3CR1-deficient lesions compared with WT lesions. Consistent with these findings, CD163 mRNA expression was significantly decreased in KO lesions. CX3CR1 deficiency attenuates endometriotic lesion growth and is associated with reduced expression of the M2 macrophage marker CD163 in a murine model of endometriosis. These findings provide the first functional in vivo evidence that the CX3CL1-CX3CR1 axis contributes to endometriosis progression and suggest that CX3CR1-mediated macrophage regulation may represent a promising non-hormonal therapeutic target for endometriosis.
Authors
- Ramanaiah Mamillapalli (ORCID: https://orcid.org/0000-0002-4022-8910)
- Hugh Stott Taylor (ORCID: https://orcid.org/0000-0003-1720-8310)
- Hanna Surmann (ORCID: https://orcid.org/0009-0002-7708-7995)
- Nimisha Gawde
Institutions
- Yale University (US)
- University Hospital Münster (DE)
Publication Details
- Journal
- Reproduction
- Published
- 2026-11-20
- DOI
- https://doi.org/10.1093/reprod/xaag149
- Primary Topic
- Endometriosis Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00